Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-11-06

FDA Approved: VOQUEZNA — Supplemental Application (Phathom Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Voquezna (vonoprazan fumarate) from Phathom Pharmaceuticals, expanding its labeling for Helicobacter pylori infe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AMOXICILLIN (AMOXICILLIN)
  • VOQUEZNA (vonoprazan fumarate)
  • clarithromycin (clarithromycin)

Snippet

SUPPL AP for VOQUEZNA (VONOPRAZAN FUMARATE)